🔗 Share this article

A shadow market for unapproved slimming drugs is being driven by social media fitness personalities and sellers on communication apps, based on recent findings.

Investigational Drug Acquiring Popularity Via Social Media

Retatrutide, which is still in clinical trials, is being promoted by online personalities for its supposed weight-reducing properties. Followers are encouraged to contact these accounts privately for supplier links, while also receiving discount codes.

Thriving Commerce on Messaging Platforms

Additionally, a flourishing trade exists on Telegram, where groups with numerous of members share comparison photos, injection guides and claims of next-day UK delivery. Sellers promote the substance there before directing customers to WhatsApp for transactions.

Learning About Retatrutide

Retatrutide is an investigational injection created by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Early trials indicate it could assist patients reduce up to 25% of their total weight. Referred to as the “triple G”, the drug is being promoted online as the successor to Ozempic.

Medical Professionals Voice Worries

However, physicians and chemists have warned that the distribution of what is still an unapproved medication in the UK is a cause for concern and could result in individuals injecting substances of unknown origin.

Several experts said the popularity for retatrutide could be linked to the increasing price of licensed weight loss treatments such as Mounjaro.

Regulatory Position and Enforcement

Marketing retatrutide on TikTok or Telegram is prohibited in the United Kingdom, as it is an unapproved drug that must not be marketed or distributed for personal consumption under the British medical regulations.

Several influencers try to circumvent the rules by calling to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but promotion and distribution can still breach medicines, advertising, and customer laws, potentially leading to fines, legal action or imprisonment.

Service Response and Content Removal

According to the social media company, the service has removed problematic content and prohibited associated hashtags and search suggestions. The organization said it was dedicated to maintaining the service secure and investing in strengthening compliance measures.

Online Trading Operations

Investigations also found groups with up to nine thousand participants marketing the experimental drug using Telegram's integrated search feature, which operates like a online catalog. Typing “retatrutide” instantly brings up groups with thousands of users, populated with images of slimming results, glowing reviews and step-by-step guides for preparing or injecting at residence.

Within moments of joining one community, a seller shared WhatsApp details, where most transactions take place. The vendor provided an instruction manual and promised delivery within two days. When asked whether the substance was genuine, one vendor said: “You can’t be sure.” Another provided a photo of a supposed testing documentation. Not one inquired about body mass, health issues or past usage.

Item Details and Costs

Within these groups, messages show dark colored packages with Royal Mail stickers, claiming to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, mixed at home with purified liquid, or ready-to-use injectors usually priced at £160 for 20mg. When questioned how long a pen should last, vendors give contradictory answers varying between a few weeks to “depends on your body”.

Platform Moderation and Security Measures

A representative for Telegram said it actively moderated harmful material on its platform including material that promoted the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Cautions

“People are injecting substances they cannot confirm. Even if the research behind retatrutide is valid, these online products may not include what they advertise,” stated a pharmacy expert, the director of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor connected the surge in interest to recent price rises for authorized weight-loss drugs such as Mounjaro. “With prices rising, individuals are using social media. But fake injections are extremely risky. You cannot know what’s inside or whether the environment they were produced in was sterile,” she explained.

Her staff has already seen patients harmed by personal administration from unconfirmed suppliers. “We recognize the disappointment, but buying from Telegram or communication platforms is gambling with your well-being,” said the doctor. “These substances could be impure or improperly measured.”

Producer Statement

A representative from Eli Lilly said retatrutide was in third stage research studies and had not been evaluated or approved by any regulatory agency anywhere in the world. “Therefore at this time no one can market [it] for personal consumption,” they explained, adding that any item “falsely representing itself as a company investigational substance not yet authorized … may subject patients to possibly significant health risks”.